Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

RPS England director confirmed for tomorrow's Twitter chat

Howard Duff and a representative from the Royal College of General Practitioners will both take part in the online debate

EXCLUSIVE

The Royal Pharmaceutical Society's director for England will take to Twitter tomorrow to field readers' questions on the society's plans to employ more pharmacists in GP surgeries.

Howard Duff will join a representative from the Royal College of General Practitioners (RCGP) on Twitter from 2pm tomorrow (July 16) to debate NHS England’s commitment to spend £15m on moving 250 pharmacists into GP practices.

Readers can share their views on the scheme – which will involve one senior pharmacist and five clinical pharmacists installed in pilot sites across England – by using the hashtag #PharmsinGPs.

NHS England announced the scheme earlier this month. Pharmacists labelled it a “positive step”, but warned that the commissioning body must continue to develop the community sector.

You can join the debate at www.twitter.com or via your Twitter app.

 

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007555

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel